DEPLOYDatabase

Robot model

Armeo

Upper limb rehabilitation exoskeleton series for arm and hand therapy..

Manufacturer
DIH Medical
Form factor
exoskeleton
Maturity
commercial
Lifecycle
active
Deployments
2

Overview

Upper limb rehabilitation exoskeleton series for arm and hand therapy.. Maturity: commercial. Maturity: commercial.

Verified vs. claimed

Maturity stage
commercial(Commercially deployed with revenue-generating operations.)
Sources on file
View all sources →

Key facts

Form Factor

exoskeleton

Maturity

commercial

Model

ArmeoPower upper-limb rehab exoskeleton by Hocoma (DIH).

Degrees of freedom (company-claimed)

7 actuated: shoulder, elbow, forearm, wrist; optional ManovoPower hand.

Indication

Severe to moderate upper-limb impairment.

Size (company-claimed)

2.05 x 0.78 x 1.66 m; about 205 kg.

Patient limits (company-claimed)

Up to 135 kg; upper arm 250 to 340 mm; forearm 310 to 420 mm.

Specs

Height cm

40

To scale

Human175 cmArmeo40 cm (1'4")

Data & sources

Web sources

2

2 sources backing this record.View all →

Pricing

No verified price is on record for Armeo. Physical-AI systems are often sold through enterprise contracts or operated as a service rather than at a public list price.

Deployments (2)

Armeo on the deployment map

View the global map

Where Armeo is verified operating. Explore the deployment map by place and type.

Free to use on your site, with a link back to DEPLOY.

Recent activity

Every change to this record is dated, sourced, and independently verified where marked.

Full change history →

Safety record

No incidents on record for Armeo.

Only active incidents are counted. Retracted incidents are excluded from this summary but remain reachable at their canonical URLs.

Sources (2)

  1. https://www.marketsandmarkets.com/ResearchInsight/exoskeleton-market.asp
  2. https://www.hocoma.com/us/solutions/armeo-power/technical-data-sheet/

Mentioned on (1)

Registry pages whose text names Armeo.

Companies (1)

DIH Holding

Common questions

What is Armeo?
Upper limb rehabilitation exoskeleton series for arm and hand therapy.. Maturity: commercial. Maturity: commercial.
How much does Armeo cost?
Armeo's price is not publicly disclosed. DEPLOY has no verified price on record for Armeo from DIH Medical. Physical-AI systems like this are often sold through enterprise contracts or operated as a service rather than at a public list price; check the manufacturer for the latest.
Is Armeo actually deployed in the real world?
Yes. Armeo is independently verified in real-world operation on the DEPLOY registry, confirmed at named deployment sites with primary sources: not a concept, render, or demo-only.
Who makes Armeo?
Armeo is made by DIH Medical, based in Zurich, Switzerland.
Where is Armeo deployed?
2 verified deployments of Armeo are on the DEPLOY registry, including at Switzerland, Europe, United States.
Can you buy Armeo?
Armeo is in commercial deployment and is sold to operators; contact the manufacturer to buy, and see the pricing section for any recorded price.
What are alternatives to Armeo?
On the DEPLOY registry, comparable exoskeleton robots to Armeo include Ant-H1 Pro, Cyberdyne HAL, German Bionic Cray X, HANK.
How does Armeo compare to Ant-H1 Pro?
Armeo and Ant-H1 Pro (Kenqing Technology · 5 deployments) are both exoskeleton robots on the DEPLOY registry. Armeo has 2 verified deployments on record. Compare both records for specs, safety, deployments, and verified-vs-claimed autonomy.
Is Armeo a top exoskeleton?
On DEPLOY's intelligence score, which blends verified deployments, safety, adoption, media, and IP signals, Armeo ranks in roughly the top 13% of exoskeleton models tracked by the registry.
What is Armeo's maturity stage?
Armeo is at the commercial stage on the DEPLOY maturity ladder (research, prototype, pilot, commercial, production). Commercial stage means production-grade deployments are operating at named customer sites.
Is Armeo safe?
Armeo has no incidents on record in the DEPLOY registry. This does not constitute a safety guarantee; it reflects the incidents DEPLOY has tracked and verified to date.
Methodology: Verified · 2 sources (no primary) · last reviewed 2026-10-31

Verification posture

Verified

Low confidence

Review state

Stable

Last reviewed 2026-10-31

Maturity + lifecycle

Maturity stage: commercial

Lifecycle: active

Architectural position

Cohort: exoskeleton

Sources by quality tier

2
unclassified
Unclassified source

The framework is documented at /methodology. Corrections at /corrections. Reviewer: DEPLOY editorial team.

Methodology surface for Armeo.